4/A//SEC Filing
MACFARLANE M DAVID 4/A
Accession 0001019687-04-002056
CIK 0000910267other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 1:35 PM ET
Size
7.9 KB
Accession
0001019687-04-002056
Insider Transaction Report
Form 4/AAmended
MACFARLANE M DAVID
Director
Transactions
- Award
Stock Option (Right to Buy)
2004-09-01+15,000→ 15,000 totalExercise: $2.37Exp: 2014-09-01→ Common Stock (15,000 underlying) - Award
Stock Option (Right to Buy)
2004-09-01+10,000→ 10,000 totalExercise: $2.37Exp: 2014-09-01→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]These options vest in equal monthly installments over a 48-month period commencing on the date of grant.
- [F2]These options vest in equal installments over a 12-month period commencing on the date of grant.
Documents
Issuer
TITAN PHARMACEUTICALS INC
CIK 0000910267
Entity typeother
Related Parties
1- filerCIK 0001182314
Filing Metadata
- Form type
- 4/A
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 1:35 PM ET
- Size
- 7.9 KB